Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report)’s stock price hit a new 52-week high during trading on Thursday . The stock traded as high as $47.96 and last traded at $47.76, with a volume of 26618 shares changing hands. The stock had previously closed at $46.85.
Analyst Ratings Changes
Separately, BNP Paribas lowered shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, December 2nd.
Check Out Our Latest Research Report on SDZNY
Sandoz Group Stock Up 1.9 %
About Sandoz Group
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Recommended Stories
- Five stocks we like better than Sandoz Group
- What is the Nasdaq? Complete Overview with History
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- When to Sell a Stock for Profit or Loss
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- How to Most Effectively Use the MarketBeat Earnings Screener
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
